Acth clinical trials

Explore recruiting acth clinical trials.

Recruiting acth studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acth trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: a randomized controlled multicenter trial

Germany

Therapeutic use (Phase IV) EU CTIS Study details

SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome

Bulgaria, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Use of [18F]FET PET-MRI to improve detection of pituitary adenomas in Cushing’s disease

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

PILOT STUDY OF THE EFFECT OF A SUBSTANCE P ANTAGONIST, APREPITANT, ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND ARTERIAL HYPERTENSION SYNDROME - (APHOS3)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

RESCUE - Effect of supplemental hydrocortisone during stress in prednisolone-induced adrenal insufficiency; A multicentre, randomised, double blinded, placebo-controlled clinical trial on health-related quality of life in patients with polymyalgia rheumatica/giant cell arteritis receiving ongoing low-dose prednisolone treatment.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effects of combined oral contraceptives on brain and behavior

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Acth trials by city

Acth in Toronto Acth in Vancouver Acth in Montreal Acth in Calgary Acth in Edmonton Acth in Ottawa Acth in Winnipeg Acth in Quebec City Acth in Hamilton Acth in Kitchener Acth in London Acth in Halifax Acth in New York Acth in Los Angeles Acth in Chicago Acth in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease